Lexicon Pharmaceuticals LXRX reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Lexicon Pharmaceuticals their estimated earnings by 11.11%, reporting an EPS of $-0.16 versus an estimate of $-0.18, which surprised analysts.
Revenue was up $6,611,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 1.12% drop in the share price the next day.
Here's a look at Lexicon Pharmaceuticals's past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.16 | -0.28 | 0.26 |
| EPS Actual | -0.13 | -0.15 | -0.04 | -0.43 |
| Revenue Estimate | 10.00K | 1.68M | 110.00K | 16.87M |
| Revenue Actual | 234.00K | 27.00K | 199.00K | 6.63M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
